Oncocyte corp shareholder Patrick W Smith acquires $34,114 in stock By Investing.com
Oncocyte corp shareholder Patrick W Smith acquires $34,114 in stock
Was macht ONCOCYTE?
Unternehmensprofil
OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Alameda, CA.
Chart der ONCOCYTE Aktie
Charttool öffnen
Aktuelle Nachrichten zu ONCOCYTE
Das berichten andere über ONCOCYTE
Wir finden für unsere Leser softwaregestützt die besten Aktien der Welt
und schreiben darüber, wie man diese handeln muss, um Geld zu verdienen.